OpenVSafe by OpenVAERS
Search V-safe

ZJ9-28610-22492

2 vaccinations 5 coded responses 26 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
037 / NH
Registered
2021-04-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-03
    Registered in v-safe
  2. 2021-04-03
    Dose 1 — Moderna
  3. 2021-04-03
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-04
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site warmth — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Free text: Injection site warmth
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Itching · Fatigue or tiredness
    Adult check-in
  7. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness, Diarrhea
    Adult check-in
  8. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-04-10
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2021-04-17
    Survey response — day 14, dose 1
    MedDRA: Arthralgia, Fatigue, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Myalgia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Day 7: Injection site itching, redness (2 dia)Day 8: Injection site pain, swelling, redness 2; fatigue; myalgia; joint painDay 9: injection site redness 3; myalgiaDay 12: fatigue, myalgia, injection site red ring 4Day 14: fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-25
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  13. 2021-05-01
    Dose 2 — Moderna
  14. 2021-05-01
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Itching · Joint pains, Fatigue or tiredness
    Adult check-in
  16. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-05-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  19. 2021-05-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  20. 2021-05-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness · None
    Adult check-in
  21. 2021-05-08
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  22. 2021-05-15
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth, Post inflammatory pigmentation change — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Fatigue, injection site tenderness, itching, warmth, swelling, post-inflammatory hyperpigmentation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-05-22
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-29
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  25. 2021-06-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-12
    Survey response — day 42, dose 2
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Increased fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-31
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  28. 2021-10-30
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Increased viscosity of upper respiratory secretion, Sinus congestion, Somnolence — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue & drowsiness, sinus congestion, thick sinus mucus
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-01
    Health check-in — 12 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-03Moderna
22021-05-01Moderna

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-04

Systemic reaction (other): Injection site warmth

Release 7 — day 14, dose 1

2021-04-17

Symptoms: Day 7: Injection site itching, redness (2 dia)Day 8: Injection site pain, swelling, redness 2; fatigue; myalgia; joint painDay 9: injection site redness 3; myalgiaDay 12: fatigue, myalgia, injection site red ring 4Day 14: fatigue

Release 8 — day 14, dose 2

2021-05-15

Symptoms: Fatigue, injection site tenderness, itching, warmth, swelling, post-inflammatory hyperpigmentation

Release 9 — day 42, dose 2

2021-06-12

Symptoms: Increased fatigue

Release 10 — 6 months, dose 2

2021-10-30

Symptoms: Fatigue & drowsiness, sinus congestion, thick sinus mucus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDIncreased viscosity of upper respiratory secretion · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDInjection site warmth ✓ ✓ ✓
SDMyalgia ✓ ✓ ✓
SDPost inflammatory pigmentation change ✓ ✓ ✓
SDSinus congestion · · ✓
SDSomnolence · · ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release